|
1
|
Hardwick KG: Checkpoint signaling: Mad2
conformers and signal propagation. Curr Biol. 15:R122–R124. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lopez-Girona A, Furnari B, Mondesert O and
Russell P: Nuclear localization of Cdc25 is regulated by DNA damage
and a 14-3-3 protein. Nature. 397:172–175. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang X, Jin DY, Ng RW, Feng H, Wong YC,
Cheung AL and Tsao SW: Significance of MAD2 expression to mitotic
checkpoint control in ovarian cancer cells. Cancer Res.
62:1662–1668. 2002.PubMed/NCBI
|
|
4
|
Li R and Murray A: Feedback control of
mitosis in budding yeast. Cell. 66:519–531. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Orr-Weaver TL and Weinberg RA: A
checkpoint on the road to cancer. Nature. 392:223–224. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoon DS, Wersto RP, Zhou W, Chrest FJ,
Garret ES, Kwon TK and Gabrielson E: Variable levels of chromosomal
instability and mitotic spindle checkpoint defects in breast
cancer. Am J Pathol. 161:391–397. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lengauer C, Kinzler KW and Vogelstein B:
Genetic instability in colorectal cancer. Nature. 386:623–627.
1997. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lengauer C, Kinzler KW and Vogelstein B:
Genetic instability in human cancer. Nature. 396:643–649. 1998.
View Article : Google Scholar
|
|
9
|
Sotillo R, Hernando E, Diaz-Rodriguez E,
Teruya-Feldstein J, Cordon-Cardo C, Lowe SW and Benezra R: Mad2
overexpression promotes aneuploidy and tumorigenesis in mice.
Cancer Cell. 11:9–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
To-Ho KW, Cheung HW, Ling MT, Wong YC and
Wang X: MAD2ΔC induces aneuploidy and promotes
anchorage-independent growth in human prostate epithelial cells.
Oncogene. 27:347–357. 2008.
|
|
11
|
Alizadeh AA, Eisen MB, Davis RE, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Cheung ST, So S, et al: Gene
expression patterns in human liver cancers. Mol Biol Cell.
13:1929–1939. 2002. View Article : Google Scholar PubMed/NCBI
|
|
13
|
Garber ME, Troyanskaya OG, Schluens K, et
al: Diversity of gene expression in adenocarcinoma of the lung.
Proc Natl Acad Sci USA. 98:13784–13789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li GQ and Zhang HF: Mad2 and p53
expression profiles in colorectal cancer and its clinical
significance. World J Gastroenterol. 9:1972–1975. 2003.PubMed/NCBI
|
|
15
|
Li GQ and Zhang HF: Mad2 and p27
expression profiles in colorectal cancer and its clinical
significance. World J Gastroenterol. 10:3218–3220. 2004.PubMed/NCBI
|
|
16
|
Zhang SH, Xu AM, Chen XF, Li DH, Sun MP
and Wang YJ: Clinicopathologic significance of mitotic arrest
defective protein2 overexpression in hepatocellular carcinoma. Hum
Pathol. 39:1827–1834. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Yin F, Du Y, Du W, Chen B, Zhang
Y, Wu K, Ding J, Liu J and Fan D: MAD2 as a key component of
mitotic checkpoint: A probable prognostic factor for gastric
cancer. Am J Clin Pathol. 131:793–801. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanaka K, Nishioka J, Kato K, Nakamura A,
Mouri T, Miki C, Kusunoki M and Nobori T: Mitotic checkpoint
protein hsMAD2 as a marker predicting liver metastasis of human
gastric cancer. Jpn J Cancer Res. 92:952–958. 2001. View Article : Google Scholar
|
|
19
|
Yu L, Guo WC, Zhao SH, Tang J and Chen JL:
Mitotic arrest defective protein 2 expression abnormality and its
clinicopathologic significance in human osteosarcoma. APMS.
118:222–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu CW, Chi CW and Huang TS: Elevated level
of spindle checkprotein MAD2 correlates with cellular mitotic
arrest, but not with aneuploidy and clinicopathological
characteristics in gastric cancer. World J gastroenterol.
10:3240–3244. 2004.PubMed/NCBI
|
|
21
|
Sotillo R, Schvartzman JM, Socci ND and
Beneztra R: Mad2- induced chromosome instability leads to lung
tumor relapse after oncogene withdrawal. Nature. 464:436–40. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scully RE, Young RH and Clement PB: Tumors
of the ovary, maldeveloped gonads, fallopian tube and broad
ligament. Atlas of tumor pathology. (3rd series). fascicle 23.
Armed Forces Institute of pathology; Washington DC: 1998,
PubMed/NCBI
|
|
23
|
Hart WR: Borderline epithelial tumors of
the ovary. Mod Pathol. 18:S33–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee KR and Scully RE: Mucinous tumors of
the ovary: a clinicopathologic study 196 borderline tumors (of
intestinal type) and carcinomas, including an evaluation of 11
cases with ‘pseudomyxoma peritonei’. Am J Surg Pathol.
28:1311–1318. 2002.PubMed/NCBI
|
|
25
|
Winter WE, Maxwell GL, Tian C, Carlson JW,
Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F and McGuire
WP: Prognostic factors for stageIII epithelial ovarian cancer: a
gynecologic oncology group study. J Clin Oncol. 25:3621–3627. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Puls LE, powell DE, DePriest PD, Gallion
HH, Hunter JE, Kryscio RJ and van Nagell JR: Transition from benign
to malignant epithelium in mucinous and serous ovarian
cystadenocarcinoma. Gynecol Oncol. 47:53–57. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Garrett AP, Lee KR, Colitti CR, Muto MG,
Berkowitz RS and Mok SC: K-ras mutation may be an early event in
mucinous ovarian tumorigenesis. Int J Gynecol Pathol. 20:244–251.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wamunyokoli FW, Bonome T, Lee JY, Feltmate
CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K,
Berkowitz RS, Mok S and Birrer MJ: Expression profiling of mucinous
tumors of the ovary identifies genes of clinicopathologic
importance. Clin Cancer Res. 12:690–700. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sinicrope FA, Ruan SB, Cleary KR, Stephens
LC, Lee JJ and Levin B: Bcl-2 and p53 oncoprotein expression during
colorectal tumorigenesis. Cancer Res. 55:237–241. 1995.PubMed/NCBI
|
